PentixaPharm

is devoted to improving the life of patients with malignant diseases through targeted molecular diagnostic and therapy based on innovative nuclear medicine.

 

OFFICE
PentixaPharm GmbH

Headquarter
Bismarckstraße 13
97080 Würzburg
Germany
Fon +49 931 991360-76

Robert-Rössle-Str. 10
13125 Berlin
Germany
Fon +49 30 9489-3220

Mail info@pentixapharm.com